Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom
Stephan Schueler(Freeman Hospital), Claudius Mahr(Medical City Dallas Hospital), Mark S. Slaughter(University of Louisville), Eleni Ismyrloglou(Medtronic (Netherlands)), Jennifer A. Beckman(University of Washington), Scott Silvestry(University of Arizona), Stelios I. Tsintzos(Medtronic (Switzerland)), William Cotts, Wayne C. Levy(Pfizer (United States)), Richard K. Cheng(University of Washington), Jonas Villinger(Medtronic (Ireland))
Cited by 16
Related Papers
The Seattle Heart Failure Model
|Circulation|2006|2k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711